Autoplaque vs SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

AI Verdict

Autoplaque specializes in the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images for heart attack risk prediction. Conversely, SensiCardiac Mobi focuses on analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological heart murmurs. While both are FDA-cleared AI tools in cardiology, their distinct data inputs (imaging vs. acoustic) and diagnostic targets (arterial plaque vs. heart murmurs) make them adjacent rather than direct competitors.

Choose Autoplaque if…

Choose Autoplaque if your clinical workflow requires precise, AI-driven quantitative analysis of coronary plaque and luminal stenosis directly from CT angiography images. This tool is ideal for cardiologists and radiologists seeking detailed insights into atherosclerotic burden for advanced heart attack risk prediction and guiding interventional strategies. It excels in providing objective, measurable data to inform complex treatment decisions based on imaging findings.

View Autoplaque →

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if you need an on-the-go, AI-powered diagnostic aid for evaluating heart murmurs during patient examinations. This mobile application is best suited for physicians who want to quickly differentiate between physiological and pathological heart sounds using an electronic stethoscope, providing immediate decision support at the point of care. It enhances the accuracy of initial murmur assessments, particularly in general practice, internal medicine, or pediatric settings.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Pricing	Unknown	Contact for pricing
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	Hosted server environment (Linux OS) with a mobile application interface
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	1 AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi's mobile application deployment offers superior portability and point-of-care convenience, making it highly accessible for physicians in various clinical settings. Autoplaque, being workstation-based software for complex image analysis, likely requires a more dedicated setup and potentially a steeper learning curve, despite its powerful features. The mobile-first design generally translates to a more intuitive and readily adoptable user experience for its specific use case.

Clinical Value

Autoplaque

Autoplaque offers profound clinical value by providing quantitative, AI-powered analysis of coronary plaques and stenoses from CT angiography, directly aiding in heart attack risk prediction and treatment guidance. This addresses a critical need in managing a leading cause of mortality with objective, detailed measurements. While SensiCardiac Mobi provides valuable decision support for heart murmur diagnosis, Autoplaque's impact on preventing major cardiac events through precise risk stratification positions it with a slightly higher clinical impact.

Pricing & Value

Tie

Both tools lack transparent public pricing, making a direct comparison of their financial value impossible. Tool B also requires the user to provide a compatible electronic stethoscope, adding an unstated external hardware cost not present with Tool A. Therefore, without any disclosed pricing details for either product, it's impossible to determine which offers better pricing or value.

Enterprise Readiness

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

SensiCardiac Mobi explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA), which are critical requirements for enterprise adoption in healthcare. Its hosted server environment also suggests a scalable infrastructure. While Autoplaque, originating from a major medical center, would likely meet similar standards, the explicit declaration by SensiCardiac Mobi provides greater transparency and assurance regarding enterprise data security and compliance.

Innovation

Autoplaque

Autoplaque demonstrates significant innovation by applying AI to perform highly sophisticated quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This moves beyond traditional qualitative assessment to provide precise, objective measurements crucial for heart attack risk prediction and treatment guidance, representing a technically advanced application in complex medical imaging. While SensiCardiac Mobi innovates by bringing AI-assisted heart murmur diagnosis to a mobile point-of-care setting, Autoplaque's deep analytical capabilities in a high-stakes domain represent a more profound technical leap in diagnostic AI.

Support & Docs

Tie

The provided structured facts offer no information regarding support or documentation for either Autoplaque or SensiCardiac Mobi. Without any details on available resources such as customer service, technical support, user manuals, or training materials, it is impossible to differentiate between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Tool Name	Autoplaque	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
Company	Cedars-Sinai Medical Center: AIM	DIACOUSTIC MEDICAL DEVICES (PTY)
Primary Function	AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images.	AI-powered mobile application that assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals.
Key Analysis/Input	Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images.	Analyzes acoustic heart signals from an electronic stethoscope.
Output/Clinical Aid	Aids in heart attack risk prediction and treatment guidance by analyzing plaque and stenosis.	Distinguishes between normal/physiological and pathological heart murmurs.

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do Autoplaque and SensiCardiac Mobi integrate into a physician's daily clinical workflow, and for what specific clinical scenarios are they best suited?

Autoplaque is a workstation-based post-processing application for CT angiography images, ideal for detailed quantitative analysis of coronary plaques and stenoses in a radiology or cardiology reading environment. SensiCardiac Mobi is a mobile application used with an electronic stethoscope at the point of care, assisting in the initial diagnosis and differentiation of heart murmurs during patient encounters.

Given their distinct approaches, which medical specialties would benefit most from each tool, and what specific clinical problems do they address?

Autoplaque is primarily for Cardiology and Radiology, focusing on advanced imaging analysis for heart attack risk prediction and treatment guidance based on atherosclerotic plaque. SensiCardiac Mobi serves Cardiology, Internal Medicine, and Pediatrics, aiding in the assessment of heart murmurs to distinguish between physiological and pathological sounds.

What are the specific data inputs required for each tool, and what detailed analytical outputs can physicians expect?

Autoplaque requires CT angiography images and provides AI-powered quantitative analysis of plaque, measurement of luminal stenoses, and automated vessel/lumen segmentation. SensiCardiac Mobi uses acoustic heart signals from an electronic stethoscope to analyze heart sounds, identifying S1, S2, suspected murmurs, and distinguishing murmur types.

What is the expected learning curve for physicians to effectively use each tool, considering their different interfaces and operational models?

Autoplaque, as a workstation-based post-processing application, may require familiarity with image analysis software, though its automated segmentations are reviewable and editable. SensiCardiac Mobi, being a mobile application, is likely designed for intuitive use at the point of care, requiring only a compatible electronic stethoscope.

What features do these tools offer to ensure the accuracy and allow for physician review or audit of the AI's analysis?

Autoplaque allows clinicians to review and edit the automated vessel, plaque, and lumen segmentations, ensuring physician oversight and correction. SensiCardiac Mobi acquires and records the acoustic heart signals, providing a record of the raw data that the AI analyzed for later review.

What are the key considerations for deploying these tools across multiple clinical sites or departments within a healthcare system?

Autoplaque is workstation-based software, implying individual installations on Windows or Mac platforms, which might require per-workstation setup. SensiCardiac Mobi operates with a hosted server environment and a mobile application interface, potentially simplifying distribution and management across multiple mobile devices and sites.